Cargando…
Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy
Poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) enhance the delivery of therapeutic enzymes for replacement therapy of lysosomal storage disorders. Previous studies examined NPs encapsulating or coated with enzymes, but these formulations have never been compared. We examined this using hyalur...
Autores principales: | Muntimadugu, Eameema, Silva-Abreu, Marcelle, Vives, Guillem, Loeck, Maximilian, Pham, Vy, del Moral, Maria, Solomon, Melani, Muro, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999373/ https://www.ncbi.nlm.nih.gov/pubmed/35409394 http://dx.doi.org/10.3390/ijms23074034 |
Ejemplares similares
-
Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders
por: del Moral, Maria, et al.
Publicado: (2023) -
Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014) -
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
por: Nathan, David G, et al.
Publicado: (2009) -
Crossing the gates of Babylon: Brain-penetrating enzyme replacement for lysosomal disorders
por: Baldo, Guilherme
Publicado: (2023) -
The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
por: Tian, Weihua, et al.
Publicado: (2019)